Shares of Nuvve Holding Corp. NVVE fell sharply during Monday’s session after the company reported worse-than-expected fourth-quarter financial results.
Nuvve Holding posted a quarterly loss of $6.98 per share, versus market estimates for a loss of $5.60 per share. The company’s sales came in at $1.65 million, compared to expectations of $3.00 million.
Nuvve Holding shares dipped 29.6% to $0.7746 on Monday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Vast Renewables Limited VSTE shares jumped 179% to $8.62 after jumping 39% on Thursday.
- CXApp Inc. CXAI gained 151% to $6.15 after the company announced a partnership with Google Cloud for acceleration of the CXAI platform.
- Sunshine Biopharma, Inc. SBFM rose 94% to $0.1176 after the company FY23 operating results.
- MediaCo Holding Inc. MDIA shares climbed 40.4% to $0.7312 after dipping more than 17% on Thursday.
- SPAR Group, Inc. SGRP gained 37% to $1.33 after the company reported Q4 financial results and announced the sale of its interest in South Africa and Brazil for roughly $22 million.
- Meta Materials Inc. MMAT gained 36.3% to $4.18. Meta Materials will host a corporate update webcast on Wednesday, April 3, 2024, at 4:30 PM EDT.
- Doma Holdings Inc. DOMA shares climbed 34% to $6.08 after the company entered a merger transaction with TRG to go private at $6.29 per share in cash.
- IM Cannabis Corp. IMCC gained 32% to $0.70. IMC applauded the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients.
- Xilio Therapeutics, Inc. XLO gained 30% to $1.40. Xilio Therapeutics shares jumped 69% on Thursday after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program.
- Trio Petroleum Corp. TPET rose 30% to $0.1099.
- Ondas Holdings Inc. ONDS gained 28.8% to $1.25 after the company reported better-than-expected fourth-quarter revenue results.
- HeartCore Enterprises, Inc. HTCR rose 22.6% to $1.19. HeartCore Enterprises announced that it has authorized a dividend payment in the amount of 2 cents per share of Common Stock.
- Mesoblast Limited MESO rose 22.4% to $6.13 after the FDA earlier in the week informed the company that the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission of the proposed Biologics License Application for remestemcel-L.
- Emeren Group Ltd SOL gained 22.3% to $2.36. The company reported fourth-quarter financial results.
- Lytus Technologies Holdings PTV. Ltd. LYT gained 20.5% to $5.58.
- Ouster, Inc. OUST gained 19.8% to $9.51.
- Global Gas Corporation HGAS gained 18.6% to $1.66.
- Iris Energy Limited IREN gained 16% to $6.26. Cantor Fitzgerald analyst Josh Siegler reiterated Iris Energy with an Overweight and maintained a $10 price target.
- GigaCloud Technology Inc. GCT gained 13.3% to $30.26.
- DouYu International Holdings Limited DOYU rose 12% to $7.38.
- Trip.com Group Limited TCOM gained 7.6% to $47.24. Citigroup analyst Brian Gong maintained Trip.com Group with a Buy and raised the price target from $53 to $55.
- Micron Technology, Inc. MU gained 6.6% to $125.69 after B of A Securities maintained a Buy rating on the stock and raised its price target from $120 to $144.
- Western Digital Corporation WDC gained 5.7% to $72.13.
Losers
- Eiger BioPharmaceuticals, Inc. EIGR shares fell 72.8% to $1.36.
- Andretti Acquisition Corp. ZPTA fell 53.6% to $6.96.
- Disc Medicine, Inc. IRON shares dipped 51.8% to $30.00 after the company reported topline results from the Phase 2 AURORA study of bitopertin in patients with EPP.
- Logistic Properties Of The Americas LPA fell 43.5% to $9.03.
- AEON Biopharma, Inc. AEON fell 41.6% to $6.77 after the company reported a fourth-quarter loss of 71 cents per share.
- Sharecare, Inc. SHCR fell 32.2% to $0.5208. announced financial results for the quarter and year ended Dec. 31, 2023. BTIG analyst David Larsen downgraded Sharecare from Buy to Neutral.
- Biora Therapeutics, Inc. BIOR fell 32.2% to $0.7480. Biora Therapeutics announced a $6 million registered direct offering priced at-the-market under Nasdaq rules.
- ENDRA Life Sciences Inc. NDRA fell 29.9% to $0.4075 after the company reported fourth-quarter results.
- Splash Beverage Group, Inc. SBEV declined 28.3% to $0.33.
- Surrozen, Inc. SRZN fell 27% to $11.00 after the company announced an approximately $192.5 million private placement of securities.
- Intellinetics, Inc. INLX dipped 26.2% to $6.52 after the company reported worse-than-expected fourth-quarter GAAP EPS results.
- Orgenesis Inc. ORGS fell 25.5% to $ 0.6126.
- GCT Semiconductor Holding, Inc. GCTS declined 20.5% to $26.26. GCT Semiconductor appointed Nelson C. Chan to Board of Directors.
- Pulse Biosciences, Inc. PLSE fell 16% to $7.32 after the company reported fourth-quarter financial results. Also, the company announced plans to initiate a rights offering of up to $60 million worth of units.
- Canopy Growth Corporation CGC declined 12% to $7.60.
- AMC Entertainment Holdings, Inc. AMC fell 12% to $3.2750.
- Borr Drilling Limited BORR fell 11.7% to $6.05.
- Rumble Inc. RUM fell 11.5% to $7.15.
- Walgreens Boots Alliance, Inc. WBA fell 7.1% to $20.16. Truist Securities analyst David Macdonald maintained Walgreens with a Hold and maintained a $25 price target.
Now Read This: Paychex Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.